ISIN | CH0519054735 |
---|---|
Valor Number | 51905473 |
Bloomberg Global ID | |
Fund Name | Credit Suisse (CH) Swiss Dividend Plus Equity Fund DB CHF |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 75 01 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | This subfund invests primarily in equities and equity-type securities (shares, dividend-right certificates, shares in cooperatives, participation certificates, etc.) of companies domiciled in or carrying out the bulk of their business activities in Switzerland. The companies are selected with the objective of achieving an expected dividend yield for the total portfolio that is above that of the Swiss Performance Index (SPI®). It may also invest in other investments permitted under the fund contract. |
Peculiarities |
Current Price * | 1,334.72 CHF | 16.04.2025 |
---|---|---|
Previous Price * | 1,335.41 CHF | 15.04.2025 |
52 Week High * | 1,458.07 CHF | 20.03.2025 |
52 Week Low * | 1,247.39 CHF | 09.04.2025 |
NAV * | 1,334.72 CHF | 16.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 172,570,171 | |
Unit/Share Assets *** | 57,148,151 | |
Trading Information SIX |
YTD Performance | +1.43% |
30.12.2024 - 16.04.2025
30.12.2024 16.04.2025 |
---|---|---|
1 month | -8.28% |
17.03.2025 - 16.04.2025
17.03.2025 16.04.2025 |
3 months | -0.69% |
16.01.2025 - 16.04.2025
16.01.2025 16.04.2025 |
6 months | -1.87% |
16.10.2024 - 16.04.2025
16.10.2024 16.04.2025 |
1 year | +5.31% |
16.04.2024 - 16.04.2025
16.04.2024 16.04.2025 |
2 years | +5.16% |
17.04.2023 - 16.04.2025
17.04.2023 16.04.2025 |
3 years | +0.30% |
19.04.2022 - 16.04.2025
19.04.2022 16.04.2025 |
5 years | +30.50% |
16.04.2020 - 16.04.2025
16.04.2020 16.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 12.07% | |
---|---|---|
Roche Holding AG | 11.05% | |
Novartis AG Registered Shares | 10.97% | |
Zurich Insurance Group AG | 6.15% | |
UBS Group AG | 5.94% | |
ABB Ltd | 5.86% | |
Givaudan SA | 4.05% | |
Swiss Re AG | 3.64% | |
Lonza Group Ltd | 3.55% | |
Compagnie Financiere Richemont SA Class A | 3.04% | |
Last data update | 30.09.2024 |
TER | 0.12% |
---|---|
TER date | 31.05.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.10% |
Ongoing Charges *** | 0.12% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |